glp-1 coverage news today insurers in Employer Plans Could Nearly Double in 2024 As Insurers Struggle With GLP-1

The results of a recent national study conducted by the Arkansas Agricultural Experiment Station found that these weight loss drugs known as Glucagon-like peptide-1 agonists or GLP-1s lead to new food and drink consumption patterns, which underscore observed changes in food and beverage marketing

,

with morphine or saline, and food and water intakes were measured before and after the injection

The finding that older participants 45 were more likely to report no change in nicotine cravings (53.3%) may suggest that the behavioral effects of GLP-1 agonists are less pronounced in older populations, possibly due to age-related neurochemical changes or lower GLP-1 receptor sensitivity